Fusarium onychomycoses in Switzerland-A mycological and histopathological study.
Fusarium species
culture
histopathology
onychomycosis
treatment
Journal
Mycoses
ISSN: 1439-0507
Titre abrégé: Mycoses
Pays: Germany
ID NLM: 8805008
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
02
06
2019
accepted:
28
06
2019
pubmed:
5
7
2019
medline:
29
1
2020
entrez:
5
7
2019
Statut:
ppublish
Résumé
Onychomycoses in temperate climates are most commonly due to dermatophytes, particularly Trichophyton rubrum. Non-dermatophyte nail infections are much less frequent, and their diagnosis requires a careful and repeated search for a potential dermatophyte that may have been overgrown in culture. A series of histological slides of suspected onychomycoses with uncommon fungal morphology prompted us to search for non-dermatophytic moulds causing dermatophytosis-like nail infections. Thirty cases were identified by culture as F solani, F oxysporum, F dimerum or F spp, and two more were only diagnosed histopathologically. None of these patients was immunocompromised. Treatment was mostly unsuccessful with terbinafine whereas itraconazole showed a moderately better treatment result; in all cases, a topical ciclopirox nail varnish in a hydroxychitosan base was added.
Substances chimiques
Antifungal Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
928-931Informations de copyright
© 2019 Blackwell Verlag GmbH.
Références
Baran R, Hay RJ, Tosti A, Haneke E. A new classification of onychomycoses. Br J Dermatol. 1998;139:567-571.
Galletti J, Negri M, Grassi FL, Kioshima-Cotica ÉS, Svidzinski TI. Fusarium spp. is able to grow and invade healthy human nails as a single source of nutrients. Eur J Clin Microbiol Infect Dis. 2015;34:1767-1772.
English MP. Nails and fungi. Br J Dermatol. 1976;94:697-701.
Tupaki-Sreepurna A, Jishnu BT, Thanneru V, et al. An assessment of in vitro antifungal activities of efinaconazole and itraconazole against common non-dermatophyte fungi causing onychomycosis. J Fungi (Basel). 2017;3(2):E20. https://doi.org/10.3390/jof3020020
Hocquette A, Grondin M, Bertlout S, Mallié M. Les champignons des genres Acremonium, Beauveria, Chryosporium, Fusarium, Onychocola, Paecilomxces, Penicillium, Scedosporium et Scopulariopsis responsables de hyalohyphomycoses. J Mycol Méd. 2005;15:136-149.
Vogelgsang S, Musa T, Bänziger I, et al. Fusarium mycotoxins in Swiss wheat: a survey of growers' samples between 2007 and 2014 shows strong year and minor geographic effects. Toxins (Basel). 2017;9(8):E246. https://doi.org/10.3390/toxins9080246
Haneke E. Mucor mycosis and neonatal fat necrosis in a premature neonate. Clear-cell syringomatous carcinoma. Fusariosis. Coll Dermato-Pathol Unna-Darier, Zürich, 1-3.9: 2000.
Nucci M, Varon AG, Garnica M, et al. Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil. Emerg Infect Dis. 2013;19:1567-1572.
Baran R, Tosti A, Piraccini BM. Uncommon clinical patterns of Fusarium nail infection: report of three cases. Br J Dermatol. 1997;136:424-427.
Calado NB, Sousa F Jr, Gomes NO, Cardoso FR, Zaror LC, Milan EP. Fusarium skin and nail infection: a report of eight cases from Natal, Brazil. Mycopathologia. 2006;161:27-31.
Yang YS, Ahn J-J, Shin M-K, Lee M-H. Fusarium solani onychomycosis of the thumbnail coinfected with Pseudomonas aeruginosa: report of two cases. Mycoses. 2011;54:168-171.
Bao F, Fan Y, Sun L, et al. Comparison of fungal fluorescent staining and ITS rDNA PCR-based sequencing with conventional methods for the diagnosis of onychomycosis. J Eur Acad Dermatol Venereol. 2018;32:1017-1021.
Guilhermetti E, Takahachi G, Shinobu CS, Svidzinski TIE. Fusarium spp. as agents of onychomycosis in immunocompetent hosts. Int J Dermatol. 2007;46:822-826.
Lawry MA, Haneke E, Strobeck K, Martin S, Zimmer B, Romano PS. Methods for diagnosing onychomycosis: a comparative study and review of the literature. Arch Dermatol. 2000;136:1112-1116.
Zukervar P, Dabin G, Secchi T, et al. Etude des onychomycoses en médecine de ville dans la région lyonnaise. J Mycol Méd. 2011;21:118-122.
Diongue K, Ndiaye M, Seck MC, Diallo MA, Badiane AS, Ndiaye D. Onychomycosis caused by Fusarium spp. in Dakar, Senegal: epidemiological, clinical, and mycological study. Dermatol Res Pract. 2017;2017:1268130.
Nelson PE, Digniani MC, Anaissie EJ. Taxonomy, biology and clinical aspects of Fusarium species. Clin Microbiol Rev. 1994;7:479-504.
Kaufmann-Lacroix C, Villers A, Gantier JC, Guillet G, Wierzbicka E, Rodier MH. Onyxis and cutaneous ulcers due to Fusarium solani in a patient with diabetes mellitus. J Mycol Méd. 2005;15:150-154.
Cobos Llardó D, Fierro Arias L, Arellano Mendoza I, Bonifaz A. Onychomycosis and its influence on quality of life. Dermatol Cosm Med Quir. 2016;14:318-327.
Ranawaka RR, Nagahawatte A, Gunasekara TA. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases. Int J Dermatol. 2015;54:1275-1282.
Park KY, Lee JW, Kim IS, et al. Longitudinal melanonychia caused by Fusarium oxysporum in immunocompetent patient. Mycoses. 2012;55:e40-41.
Wu CY, Chen GS, Lan CC. Onychomycosis caused by Fusarium solani in a woman with diabetes. Clin Exp Dermatol. 2009;34:e772-774.
Bourgeois GP, Cafardi JA, Sellheyer K, Andea AA. Disseminated Fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature. Cutis. 2010;85:191-194.
Ocampo-Garza J, Herz-Ruelas ME, Chavez-Alvarez S, et al. Disseminated fusariosis with endophthalmitis after skin trauma in acute lymphoblastic leukaemia. J Eur Acad Dermatol Venereol. 2016;30:e121-e123.
Gupta AK, De Doncker P, Scher RK, et al. Itraconazole for the treatment of onychomycosis. Int J Dermatol. 1998;37:303-308.
Garbino J, Uckay I, Rohner P, Lew D, Van Delden C. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature. Transpl Int. 2005;18:613-618.
Khetan S, Khetan P, Katkar V, Kusulkar M. Urinary tract infection due to Fusarium oxysporum in an immunocompetent patient with chronic kidney disease. J Biomed Res. 2018;32:157-160.
Tupaki-Sreepurna A, Thanneru V, Natarajan S, et al. Phylogenetic diversity and in vitro susceptibility profiles of human pathogenic members of the Fusarium fujikuroi species complex isolated from South India. Mycopathologia. 2018;183:529-540.
Khurana A, Chowdhary A, Sardana K, Gautam RK, Sharma PK. Complete cure of Fusarium solani sp. complex onychomycosis with Qs NdYAG treatment. Dermatol Ther. 2018;31:e12580.
Espírito-Santo GAD, Pereira Leite D, Hoffmann-Santos HD, Basili Dias L, Hahn RC. 1340 nm laser therapy for onychomycosis: Negative results of prospective treatment of 72 toenails and a literature review. J Clin Aesthet Dermatol. 2017;10:56-61.